NOD2 in monocytes negatively regulates macrophage development through TNFalpha.

Area of Science:

• Immunology
• Gastroenterology
• Cell Biology

Background:

• Crohn's Disease (CD) is linked to NOD2 risk alleles, with current theories suggesting monocyte recruitment leads to pathogenic macrophages.
• An alternative hypothesis posits that NOD2 may inhibit monocyte differentiation into macrophages.

Purpose of the Study:

• To investigate the role of NOD2 in regulating monocyte differentiation into macrophages in the gut.
• To explore the potential therapeutic implications of NOD2 function in CD.

Main Methods:

• Utilized germ-free mice, mixed bone marrow chimeras, and in vitro culture systems.
• Examined monocyte-derived dendritic cells (mo-DCs) and macrophage differentiation.
• Employed pharmacological inhibitors and analyzed responses to muramyl dipeptide (MDP).

Main Results:

• NOD2 deficiency led to reduced mo-DC frequency in the colon, independent of microbiota changes.
• Impaired mo-DC reconstitution was observed in NOD2-deficient bone marrow chimeras.
• NOD2 activation inhibits mTOR-mediated macrophage differentiation via a TNFα-dependent pathway, a process disrupted by NOD2 mutations.

Conclusions:

• NOD2 negatively regulates macrophage development through a feed-forward loop.
• This regulatory pathway presents a potential target for overcoming resistance to anti-TNF therapy in CD.